Harvard Bioscience Q4 2023 Earnings Preview

• Harvard Bioscience (NASDAQ:HBIO) is scheduled to announce Q4 earnings results on Thursday, March 7th, before market open.
• The consensus EPS Estimate is $0.05 (+25.0% Y/Y) and the consensus Revenue Estimate is $28.6M (+0.7% Y/Y).
• Over the last 2 years, HBIO has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.

More on Harvard Bioscience

• Seeking Alpha’s Quant Rating on Harvard Bioscience
• Historical earnings data for Harvard Bioscience
• Financial information for Harvard Bioscience